Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul;16(3):391-396.
doi: 10.1016/j.cpet.2021.03.004.

Prostate Cancer Theranostics: PSMA Targeted Therapy

Robert Seifert  1 , Ian L Alberts  2 , Ali Afshar-Oromieh  2 , Kambiz Rahbar  3
Affiliations
Review

Prostate Cancer Theranostics: PSMA Targeted Therapy

Robert Seifert et al. PET Clin. 2021 Jul.

Abstract

Prostate-specific membrane antigen (PSMA) has been the subject of numerous studies within the last 3 decades. PSMA-targeted imaging and therapy have significantly changed the management of patients with prostate cancer in various disease stages, especially in advanced metastasized castration-resistant prostate cancer. Lutetium-177-conjugated PSMA-617 or PSMA-I&T (Lu-PSMA) has shown promising results in multicenter retrospective and monocenter prospective trials. The aim of this review is to provide an overview of the history and current and future developments of PSMA-targeted therapy. A special focus of this review is on PSMA PET-guided management of patients receiving PSMA-targeted radioligand therapy.

Keywords: PSMA; Prostate cancer; Prostate-specific membrane antigen; Theranostics.

PubMed Disclaimer

LinkOut - more resources